Filing Details
- Accession Number:
- 0001562180-20-002257
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-05 19:37:31
- Reporting Period:
- 2020-03-03
- Accepted Time:
- 2020-03-05 19:37:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1636422 | Health Catalyst Inc. | HCAT | Services-Computer Programming, Data Processing, Etc. (7370) | 453337483 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1780970 | Dale Sanders | C/O Health Catalyst, Inc. 3165 Millrock Drive, #400 Salt Lake City UT 84121 | Chief Technology Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-03-03 | 27,500 | $10.30 | 88,728 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-03-03 | 23,600 | $28.32 | 65,128 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-03-03 | 3,900 | $29.33 | 61,228 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-03-03 | 27,500 | $0.00 | 27,500 | $10.30 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
136,166 | 2019-10-28 | 2025-11-09 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on November 26, 2019, in accordance with Rule 10b5-1.
- Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $27.96 to $28.88, inclusive.
- Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $28.97 to $29.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3).
- 25% of the 163,666 shares underlying the options vested in an annual installment and the remaining balance vested in equal monthly installments until the option was vested in full on Oct. 28, 2019.